Lan Peng, M.D.

Download Curriculum Vitae

Dr. Peng is an Associate Professor of Pathology. She joined UT Southwestern Medical Center in 2011. Dr. Peng’s clinical interests and expertise include neoplastic and non-neoplastic liver, pancreas and gastrointestinal pathology, and liver transplant pathology. Dr. Peng also have strong passion in innovative translational research, her current research interests include clinicopathological, immunohistochemical, and molecular characterization of gastrointestinal, liver and pancreas neoplasm as well as inflammatory diseases.

 

Dr. Peng has served as co-investigator for about 10 research grants, including R01s, U01s, many other NIH/NCI grants as well as grants from various foundations. Her works were published in high-profile journals including Cell reports and Lancet Oncology.

Medical School

Hunan Medical College (1992)

Residency

New York University Hospital (2007), Pathology

Fellowship

UT MD Anderson Cancer Center (2008), Surgical Pathology

Fellowship

Mount Sinai Medical Center (2009), Liver & Gi Pathology

Featured Publications

Nuclear localization of Argonaute 2 is affected by cell density and may relieve repression by microRNAs.

Johnson KC, Kilikevicius A, Hofman C, Hu J, Liu Y, Aguilar S, Graswich J, Han Y, Wang T, Westcott JM, Brekken RA, Peng L, Karagkounis G, Corey DR, Nucleic Acids Res 2023 Dec

A Rare Case of a Pancreatic Intraductal Oncocytic Papillary Neoplasm Associated With Invasive Adenocarcinoma Presenting as a Gastric Mass.

Younes AI, Hu X, Peng L, Chi Z, Cureus 2023 Oct 15 10 e47886

Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma.

Yin J, Elias R, Peng L, Levonyak N, Asokan A, Christie A, Kubiliun N, Brugarolas J, Hammers HJ, Clin Genitourin Cancer 2022 Feb

GATA3 positivity is associated with poor prognosis in patients with oesophageal squamous cell carcinoma.

Chi Z, Balani J, Gopal P, Hammer S, Xu J, Peng L, J Clin Pathol 2022 Jan

Characterization of Desmoglein 3 (DSG3) as a Sensitive and Specific Marker for Esophageal Squamous Cell Carcinoma.

Chi Z, Balani J, Gopal P, Hammer S, Lewis CM, Peng L, Gastroenterol Res Pract 2022 2022 2220940

Variations of P40 and P63 Immunostains in Different Grades of Esophageal Squamous Cell Carcinoma: A Potential Diagnostic Pitfall.

Chi Z, Balani J, Gopal P, Peng L, Hammer S, Appl Immunohistochem Mol Morphol 2021 May

Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.

Yamashita R, Long J, Longacre T, Peng L, Berry G, Martin B, Higgins J, Rubin DL, Shen J, Lancet Oncol 2021 01 22 1 132-141

Dietary simple sugars alter microbial ecology in the gut and promote colitis in mice.

Khan S, Waliullah S, Godfrey V, Khan MAW, Ramachandran RA, Cantarel BL, Behrendt C, Peng L, Hooper LV, Zaki H, Sci Transl Med 2020 Oct 12 567

NLRP12 suppresses hepatocellular carcinoma via downregulation of cJun N-terminal kinase activation in the hepatocyte.

Udden SN, Kwak YT, Godfrey V, Khan MAW, Khan S, Loof N, Peng L, Zhu H, Zaki H, Elife 2019 Apr 8

restrains pancreatic neoplasia formation.

Wang SC, Nassour I, Xiao S, Zhang S, Luo X, Lee J, Li L, Sun X, Nguyen LH, Chuang JC, Peng L, Daigle S, Shen J, Zhu H Gut 2018 Oct

 Featured Books

Targeted gene repair in mammalian cells using chimerical Oligonucleotides.. In Genetic Engineering: Principles and Methods

Kmiec EB, Ye S and Peng L (2001). New York, USA, Springer